The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial

Background: Patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) consists of a heterogenic population and improvement in identification of a specific risk profile is needed. In this study we aimed to obtain better insight in the role of different biomarkers for patients undergoing a rou...

Full description

Bibliographic Details
Main Authors: Nick D. Fagel, Maarten A. Vink, Antonius A.C.M. Heestermans, Robert K. Riezebos
Format: Article
Language:English
Published: IMR Press 2023-04-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/24/4/10.31083/j.rcm2404117